IDSA News - September 2015  (Plain Text Version)

Return to Graphical Version

 

In this issue:
PATIENT CARE AND SCIENCE
•  CDC Investigates Multistate Outbreak of Listeriosis Linked to Soft Cheeses
POLICY AND ADVOCACY
•  IDSA Leaders Appointed to New Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
•  IDSA and HIVMA “Rally for Medical Research”
•  S-FAR Holds Strategy Meeting with over 50 Partner Organizations
GLOBAL ID
•  Science Speaks Reports on New HIV and TB Resources
EDUCATION AND RESOURCES
•  IDSA Education and Research Foundation to Host Donors’ Lounge at IDWeek 2015
•  Thank You—We Couldn't Have Done it Without You
•  IDSA Education and Research Foundation Announces New Award in Memory of Robert C. Moellering, MD, FIDSA
•  ASP Announces Accreditation Seminar
YOU AND YOUR COLLEAGUES
•  Member Report
FROM THE PRESIDENT
•  From Ebola, Antibiotic Resistance and ABIM to Strategic Planning…A Year in Review
TOP STORIES
•  Bipartisan Antibiotic and Diagnostic Tax Credit Bill Introduced in Congress
•  Drug Company Reverses 5,000% Increase in Drug Price
•  IDSA Journal Club

 

CDC Investigates Multistate Outbreak of Listeriosis Linked to Soft Cheeses

Teaser here

The Centers for Disease Control and Prevention (CDC), together with public health officials in several states and the U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of Listeria monocytogenes infections (listeriosis). According to an alert from the CDC, five rare DNA fingerprints of Listeria are included in this investigation. Twenty-four people infected with one of the closely related Listeria strains have been reported from nine states since August 8, 2010. Twenty-one people have been hospitalized. Five illnesses were pregnancy-related; one resulted in a fetal loss. One death was reported from Ohio. The investigation has not conclusively identified the source of this outbreak, but most ill people interviewed reported eating soft cheese before becoming ill but the investigation is ongoing.

IDSA offers two email services to help members stay informed of updates from FDA and CDC. Content includes a range of topics, including drug warnings, recalls, and outbreak investigations. Recent alerts have included:

US Compounding, Inc. Issues Voluntary Nationwide Recall of All Sterile Compounded Products FDA Alert (9/24/2015)

Avycaz (ceftazidime and avibactam): Drug Safety Communication - Dose Confusion and Medication Errors FDA Alert (9/22/2015)

Travelers from Liberia no longer require U.S. entry screening for Ebola CDC Alert (9/3/2015)

IDSA members can sign up for these services online. (To subscribe, check the appropriate boxes to receive CDC’s Health Alert Network [HAN] messages and/or alerts from FDA, and provide your email address and name where indicated.)

Is Your Facility Experiencing Antibiotic Shortages?
IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at schang@idsociety.org.